Source: Anadolu Agency

A Turkish pharmaceutical company said Friday it has developed a generic drug containing hydroxychloroquine sulphate, which doctors have been using to treat COVID-19-related symptoms.

As pharmaceutical companies race to find a cure for the deadly virus globally, Turkish Kocak Farma company official Cem Kocak said that they too are playing their part.

Kocak noted that Turkey actively contributes to global efforts in finding a cure for coronavirus via its domestic companies and said the use of hydroxychlorine-based malaria drug has been successful in the treatment of COVID-19 for the time being.

Underlining that the currently used hydroxychlorine-based drug is from a foreign pharmaceutical company, Kocak said: “We took action to generate a domestic product. We began our journey and our research to not only meet the country’s medicine needs but also to contribute to the country’s economy.”

“As a result of the studies, we have obtained the permit for our product with the active ingredient hydroxychloroquine sulphate used in the treatment of COVID-19,” he added.

The permit is applicable to 200 milligrams of tablets.

What is generic medicine?

Generic medicine is a drug that is an alternative to an original drug.

Generic drugs contain the same active ingredients as the original brand products.

Read the original article here: https://www.aa.com.tr/en/turkey/turkish-company-develops-hydroxychloroquine-drug

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »